Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Chastain

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
Contemporary Clinical Trials|November 11, 2022
Distribution of age, sex, race, and ethnicity in COVID-19 clinical drug trials in the United States: A reviewDaniel B Chastain, Vishwa S Patel, Alexandria M Jefferson, et al.
Journal of Hospital Medicine|June 26, 2020
Empiric Therapies for COVID-19: Destined to Fail by Ignoring the Lessons of HistoryGregory S Canfield, Jonathan S Schultz, Sam Windham, et al.
Journal of Primary Care & Community Health|April 15, 2022
Clinical Severity on Hospital Admission for COVID-19: An Analysis of Social Determinants of Health From an Early Hot Spot in the Southeastern U.SDaniel B Chastain, Sharmon P Osae, Geren M Thomas, et al.
Open Forum Infectious Diseases|June 18, 2024
Risk of Invasive Fungal Infections in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors: A Case-Control Propensity Score-Matched AnalysisNelson Iván Agudelo Higuita, Daniel B Chastain, Brian Scott, et al.
European Journal of Pharmacology|November 6, 2023
A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitisAbdulaziz H Alanazi, Daniel B Chastain, Madhuri Rudraraju, et al.
Current Microbiology|November 1, 2023
Diabetes Mellitus Type 2 as a Risk Factor and Outcome Modifier for Cryptococcosis in HIV Negative, Non-transplant Patients, a Propensity Score Match AnalysisVanessa M Kung, Carolina Ferraz, Matthew Kennis, et al.
Therapeutic Advances in Infectious Disease|October 24, 2022
Seasonal variations and risk factors of <i>Streptococcus pyogenes</i> infection: a multicenter research network studyMatthew Kennis, Alex Tagawa, Vanessa M Kung, et al.
Mycoses|March 1, 2024
Glucocorticoids as a risk factor for infection and adverse outcomes in non-HIV and non-transplant patients with cryptococcal meningitisLuke Kim, Carolina Ferraz, Michaele Francesco Corbisiero, et al.
The American Journal of Tropical Medicine and Hygiene|May 28, 2024
Clinical Characteristics and Outcomes of Disseminated Strongyloidiasis in the United States-A Multicenter Network AnalysisAndrés F Henao-Martínez, Christian Olivo Freites, Nelson I Agudelo Higuita, et al.
The Annals of Pharmacotherapy|May 4, 2026
<i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV, Non-HCT Adults: Real-World Patterns of Overlapping Immunosuppression and PJP-Active TherapyDaniel B Chastain, Dustin M Solorzano-Salazar, Aditya Mantha, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Contemporary Clinical Trials|November 11, 2022
Distribution of age, sex, race, and ethnicity in COVID-19 clinical drug trials in the United States: A reviewDaniel B Chastain, Vishwa S Patel, Alexandria M Jefferson, et al.
Journal of Hospital Medicine|June 26, 2020
Empiric Therapies for COVID-19: Destined to Fail by Ignoring the Lessons of HistoryGregory S Canfield, Jonathan S Schultz, Sam Windham, et al.
Journal of Primary Care & Community Health|April 15, 2022
Clinical Severity on Hospital Admission for COVID-19: An Analysis of Social Determinants of Health From an Early Hot Spot in the Southeastern U.SDaniel B Chastain, Sharmon P Osae, Geren M Thomas, et al.
Open Forum Infectious Diseases|June 18, 2024
Risk of Invasive Fungal Infections in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors: A Case-Control Propensity Score-Matched AnalysisNelson Iván Agudelo Higuita, Daniel B Chastain, Brian Scott, et al.
European Journal of Pharmacology|November 6, 2023
A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitisAbdulaziz H Alanazi, Daniel B Chastain, Madhuri Rudraraju, et al.
Current Microbiology|November 1, 2023
Diabetes Mellitus Type 2 as a Risk Factor and Outcome Modifier for Cryptococcosis in HIV Negative, Non-transplant Patients, a Propensity Score Match AnalysisVanessa M Kung, Carolina Ferraz, Matthew Kennis, et al.
Therapeutic Advances in Infectious Disease|October 24, 2022
Seasonal variations and risk factors of <i>Streptococcus pyogenes</i> infection: a multicenter research network studyMatthew Kennis, Alex Tagawa, Vanessa M Kung, et al.
Mycoses|March 1, 2024
Glucocorticoids as a risk factor for infection and adverse outcomes in non-HIV and non-transplant patients with cryptococcal meningitisLuke Kim, Carolina Ferraz, Michaele Francesco Corbisiero, et al.
The American Journal of Tropical Medicine and Hygiene|May 28, 2024
Clinical Characteristics and Outcomes of Disseminated Strongyloidiasis in the United States-A Multicenter Network AnalysisAndrés F Henao-Martínez, Christian Olivo Freites, Nelson I Agudelo Higuita, et al.
The Annals of Pharmacotherapy|May 4, 2026
<i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV, Non-HCT Adults: Real-World Patterns of Overlapping Immunosuppression and PJP-Active TherapyDaniel B Chastain, Dustin M Solorzano-Salazar, Aditya Mantha, et al.
Pageof 17